A consortium including Elliott Investment Management L.P. is in advanced talks to acquire Syneos Health, Inc. (NasdaqGS:SYNH), according to people familiar with the matter. The investor group, which also includes former KKR & Co. Inc. (NYSE:KKR) dealmaker Jim Momtazee's Patient Square Capital, LP and Veritas Capital Fund Management, L.L.C, could announce a deal for the drug-research services company as soon as this week, the people said.
1st Jan change | Capi. | |
---|---|---|
+63.57% | 62.59B | |
-2.15% | 41.18B | |
+44.76% | 40.29B | |
-8.93% | 27.9B | |
+12.19% | 26.21B | |
-21.85% | 19.09B | |
+3.62% | 13.08B | |
+25.39% | 12.26B | |
+27.30% | 12.05B |